NASDAQ:TCRT
Alaunos Therapeutics, Inc. Stock News
$1.33
+0.0100 (+0.758%)
At Close: May 09, 2024
Alaunos (TCRT) to Wind Down Sole Clinical Study, Stock Dips 65%
11:44am, Wednesday, 16'th Aug 2023
Due to a lack of funding needs, Alaunos (TCRT) decides to end its only clinical study. The company will instead focus on its hunTR TCR discovery platform and explore broad strategic alternatives.
Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023
08:30am, Wednesday, 03'rd May 2023
HOUSTON, May 03, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor (TCR) cell therapy company advancing a clinical-stag
Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April
05:30pm, Wednesday, 29'th Mar 2023
HOUSTON, March 29, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor (TCR) cell therapy company advancing a clinical-st
Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
04:01pm, Tuesday, 28'th Feb 2023
HOUSTON, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced that
Is Alaunos Therapeutics (TCRT) Outperforming Other Medical Stocks This Year?
11:18am, Tuesday, 24'th Jan 2023
Here is how Alaunos (TCRT) and Autolus Therapeutics PLC Sponsored ADR (AUTL) have performed compared to their sector so far this year.
5 Stocks to Buy as the Drug Industry Bets Big on Innovation
10:33am, Wednesday, 18'th Jan 2023
Innovation is expected to continue driving growth in the Medical-Drugs industry in 2023. DYN, SLN, TCRT, ASRT and ACER may prove to be good additions to one's portfolio.
After Plunging 42% in 4 Weeks, Here's Why the Trend Might Reverse for Ziopharm (TCRT)
11:17am, Wednesday, 30'th Nov 2022
Ziopharm (TCRT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising
Alaunos Therapeutics Still Waiting For Home Run
02:13pm, Monday, 21'st Nov 2022
First-in-human data from two patients using TCR-T cell therapy produced, at best, one partial response. While not targeting solid tumors, approved CAR-T cell therapies do demonstrate high complete res
New Strong Buy Stocks for November 18th
09:10am, Friday, 18'th Nov 2022
VIRC, TCRT, AINC, CWEN and WHF have been added to the Zacks Rank #1 (Strong Buy) List on November 18, 2022.
Alaunos Therapeutics, Inc. (TCRT) Q3 2022 Earnings Call Transcript
02:10pm, Monday, 14'th Nov 2022
Alaunos Therapeutics, Inc. (NASDAQ:TCRT ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Alex Lobo - Stern Investor Relations Kevin Boyle Senior - Chief Executive O
HOUSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced a post
Hot Penny Stocks To Watch As The Stock Market Crash Continues
02:30pm, Monday, 26'th Sep 2022
Hot penny stocks to add to your watch list this week. Is it time to buy?
Hot Penny Stocks To Watch Today As Stock Market Crash Continues
11:50am, Tuesday, 20'th Sep 2022
Hot penny stocks to watch today. The post Hot Penny Stocks To Watch Today As Stock Market Crash Continues appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Making Money With Penny Stocks When the Market Crashes
11:30am, Sunday, 18'th Sep 2022
How to make money with penny stocks during a market crash The post Making Money With Penny Stocks When the Market Crashes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
Why Alaunos Therapeutics Stock Is Soaring Today
11:19am, Friday, 16'th Sep 2022
The biotech is rebounding after yesterday's big sell-off.